Key result
Treatment with the isolated receptor-binding domain of Ang1 (DeltaAng1) reduced vascular density and simplified vessel branching patterns independently of Tie2 phosphorylation.
The isolated receptor-binding domain of Ang1 can reduce vascular density and mediate endothelial effects independently of Tie2 phosphorylation, suggesting a potential role in anti-angiogenic therapies.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Tie2-independent anti-angiogenic effects; leaves open translation to clinical use.
The vessel-stabilizing effect of angiopoietin-1 (Ang1)/Tie2 receptor signaling is a potential target for pro-angiogenic therapies as well as anti-angiogenic inhibition of tumor growth. We explored the endothelial and vascular specific activities of the Ang1 monomer, i.e. dissociated from its state as an oligomer. A truncated monomeric Ang1 variant (i.e. DeltaAng1) containing the isolated fibrinogen-like receptor-binding domain of Ang1 was created and recombinantly produced in insect cells. DeltaAng1 ligated the Tie2 receptor without triggering its phosphorylation. Moreover, monomeric DeltaAng1 was observed to bind alpha(5)beta(1) integrin with similar affinity compared with Tie2. Unexpectedly, in vitro treatment of endothelial cells with DeltaAng1 showed some of the known effects of full-length Ang1, including inhibition of basal endothelial cell permeability and stimulation of cell adhesion as well as activation of MAPKs. Local treatment of the microvasculature of the developing chicken chorioallantoic membrane with the DeltaAng1 protein led to profound reduction of the mean vascular length density, thinning of vessels, and reduction of the number of vessel branching points. Similar effects were observed in side-by-side experiments with the recombinant full-length Ang1 protein. These effects of simplification of the vessel branching pattern were confirmed through local gene transfer with lentiviral particles encoding DeltaAng1 or full-length Ang1. Together, our findings suggest a potential use for exogenous Ang1 in reducing rather than increasing vascular density. Furthermore, we show that the isolated receptor-binding domain of Ang1 is capable of mediating some effects of full-length Ang1 independently of Tie2 phosphorylation, possibly through integrin ligation.
No takes yet. Share an insight, caveat, or question.
Weber et al. (2005) studied Angiogenesis and vessel organization. DeltaAng1 (truncated monomeric Ang1 variant) vs. Full-length Ang1 protein was evaluated on Vascular length density, vessel thinning, and number of vessel branching points. Treatment with the isolated receptor-binding domain of Ang1 (DeltaAng1) reduced vascular density and simplified vessel branching patterns independently of Tie2 phosphorylation.
Synapse has enriched 10 related papers. Consider them for comparative context: